持続血糖測定器(CGM)の世界市場

◆英語タイトル:GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET FORECAST 2017-2025
◆商品コード:INKW704012
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年4月1日
◆ページ数:145
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Multi LicenseUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、持続血糖測定器(CGM)の世界市場について調査・分析し、持続血糖測定器(CGM)の世界市場動向、市場予測、セグメント別分析、主要地域別分析(アメリカ市場、ヨーロッパ市場、アジア市場)、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Key Findings
The global CGMS market was valued at $878 million in the year 2016 and is expected to reach a value of $13672 million by 2025 with a CAGR of 36.7%. The global continuous glucose monitoring system market is poised to grow during the forecast period of 2017-2025. Various reasons for growth of the continuous glucose monitoring system market are exponential increase in number of people suffering from diabetes, higher awareness, and approval of artificial pancreas, better healthcare infrastructure and ease of using continuous glucose monitoring devices.

Continuous glucose monitoring system is used to measure blood sugar in both hyperglycemic and hypoglycemic diabetic patients. Continuous glucose monitoring involves measuring glucose levels are regular intervals. It helps to get a better insight into glucose level trends. This system consists of a glucose sensor that is placed subcutaneously to get glucose level reading in the tissue fluid. Information about glucose level is transmitted using radio waves from the sensor to a receiver display. This monitoring also provides information about HbA1C and fructosamine levels.

Incidences of diabetes have been rising at an alarming rate all over the world. The WHO data indicates that 422 million people currently have diabetes and it is expected by 2030, there will be 642 million people affected by this, all over the world. It is more prevalent in middle to low-income countries. Almost 12% of global health expenditure is spent on diabetes. Advances in technological innovation and approval of artificial pancreas have help in management and control of diabetes.

Continuous glucose monitoring system market is segmented on the basis of geography, product type and application. There are various kinds of product types that comprise a continuous glucose monitoring system. These are transmitters and receivers, insulin pumps and sensors. Sensors can be non-invasive glucose sensors, minimally invasive glucose sensors, real time sensors and holter type retrospective sensors. These glucose monitors have applications in hospitals, home and at diagnostics and clinic.

Market Insights
Market drivers for continuous glucose monitoring system are huge rise in incidences of diabetes, growing awareness about health in developing economies, changing and sedentary lifestyle, increasing need for efficient and easy blood monitoring and launch of artificial pancreas.

Transmitters and receivers is the product type with the largest market share currently. It is expected that in the forecast period, insulin pumps will show good CAGR and capture a big market share. Sensors too are expected to report effective growth rate in the forecast period.

In terms of end-users, currently hospitals have the largest market share. Going forward, it is expected that the home healthcare segment will show highest CAGR.

Factors that will restrain market growth are high cost of continuous glucose monitoring systems, strict regulatory norms and insufficient reimbursement options.

Figure: Global Continuous glucose monitoring system Market by Geography (%) in 2016

Source: Inkwood Research

Regional Insights
Market regions that are covered in the report are North America, Europe, Asia-Pacific and RoW. North America has the largest market share of continuous glucose monitoring system market. There is awareness about advantages of using continuous glucose monitoring systems, better healthcare infrastructure, growing incidences of diabetes due to sedentary lifestyle and high healthcare expenditure. Europe also has a good market share due to high awareness and good healthcare infrastructure.

Asia-Pacific market is expected to report highest growth in the years 2017-2025. Increasing awareness, higher spending power and more number of people suffering from chronic diseases and growing investment in healthcare infrastructure by government will be the market drivers for growth of continuous glucose monitoring system market in Asia Pacific region. Higher rate of obesity cases and more knowledge about managing the disease will lead to market growth.

Competitive Insights

The major market players for continuous glucose monitoring system are Novo Nordisk, Dexcom Inc., Roche, Animas Corporation, Medtronic Inc., Insulet Corporation, Bayer AG, Ypsomed AG, Glysens Inc. and Abbott Laboratories. Established companies have a good hold on the continuous glucose monitoring system market due to high cost of investment needed to enter and sustain in the market. Companies are forming alliances and are going for mergers and acquisitions to strengthen their market position. Organizations are investing in research and development to come up with novel and innovative products that will capture new market share.

【レポートの目次】

RESEARCH SCOPE
1.1 STUDY GOALS
1.2 SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1 SOURCES OF DATA
2.2 BOTTOM UP APPROACH
2.3 TOP DOWN APPROACH
2.4 DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1 MARKET SUMMARY & KEY FINDINGS OF THE STUDY
4. MARKET OVERVIEW
4.2 DRIVERS AND IMPACT
4.2.1 INCREASE IN DIABETIC POPULATION
4.2.2 INCREASE IN HEALTHCARE EXPENDITURE
4.2.3 INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.2.4 TECHNOLOGY INTEGRATION
4.3.5 INCREASING CGMS AFFORDABILITY
4.3.6 LOW PRICE OF TECHNOLOGY
4.3 RESTRAIN AND IMPACT
4.3.1 HINDERANCE FROM GOVERNMENT REGULATIONS
4.3.2 SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
5. MARKET BY COMPONENT TYPE
5.1 SENSORS
5.2 TRANSMITTERS AND RECEIVERS
5.3 INSULIN PUMP
6. MARKET BY APPLICATION
6.1 DIAGNOSTICS AND CLINICS
6.2 HOSPITALS
6.3 HOME SETTINGS
7 KEY ANALYTICAL
7.1 5 FORCES ANALYSIS
7.1.1 THREAT OF NEW ENTRANT
7.1.2 THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
7.1.3 BARGAINING POWER OF BUYERS
7.1.4 BARGAINING POWER OF SUPPLIER
7.1.5 INTENSITY OF COMPETITIVE RIVALRY
7.2 TOP THREE MARKET TRENDS
7.2.1 INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
7.2.2 LACK OF KNOWLEDGE
7.2.3 REDUCTION OF HANDLING EFFORTS
7.3 TOP THREE GEOGRAPHIES
7.4 MERGER AND ACQUISITIONS
8. REGIONAL ANALYSIS
8.1 NORTH AMERICA
8.1.1 THE US
8.1.2 CANADA
8.2 EUROPE
8.2.1 GERMANY
8.2.2 THE UK
8.3 FRANCE
8.4 REST OF EUROPE (RoE)
8.3 ASIA PACIFIC (APAC)
8.3.1 CHINA
8.3.2 INDIA
8.3.3 AUSTRALIA
8.3.4 REST OF ASIA PACIFIC (RoAP)
8.4 LATIN AMERICA
8.5 REST OF THE WORLD (RoW)
9. COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MEDTRONIC
9.2.1 BUSINESS PROFILE
9.2.2 PRODUCT PORTFOLIO
9.2.3 REVENUE ANALYSIS
9.2.4 STRATEGIC INPUTS
9.2.5SCOT Analysis
9.3 DEXCOM
9.3.1 BUSINESS PROFILE
9.3.2 PRODUCT PORTFOLIO
9.3.3 REVENUE ANALYSIS
9.3.4 STRATEGIC INPUTS
9.3.5 SCOT ANALYSIS
9.4 ABBOTT
9.4.1 BUSINESS PROFILE
9.4.2 PRODUCT PORTFOLIO
9.4.3 REVENUE ANALYSIS
9.4.4 STRATEGIC INPUTS
9.4.3 SCOT ANALYSIS
9.5 JOHNSON and JOHNSON
9.5.1 BUSINESS PROFILE
9.5.2 PRODUCT PORTFOLIO
9.5.3 REVENUE ANALYSIS
9.5.4 STRATEGIC INPUTS
9.5.5SCOT ANALYSIS
9.6 INSULET CORP
9.6.1 BUSINESS PROFILE
9.6.2 PRODUCT PORTFOLIO
9.6.3 REVENUE ANALYSIS
9.6.4 SCOT ANALYSIS
9.7 TANDEM DIABETES
9.7.1 BUSINESS PROFILE
9.7.2 REVENUE ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 STRATEGIC INPUTS
9.7.5 SCOT ANALYSIS
9.8 ECHO THERAPEUTICS
9.8.1 BUSINESS PROFILE
9.8.2 REVENUE ANALYSIS
9.9 ROCHE DIAGNOSTICS
9.9.1 BUSINESS PROFILE
9.9.2 PRODUCT PORTFOLIO
9.9.3 REVENUE ANALYSIS
9.9.4 STRATEGIC INPUTS
9.9.5 SCOT ANALYSIS
9.10 NEMAURA MEDICAL INC.
9.10.1 BUSINESS PROFILE
9.10.2 PRODUCT PORTFOLIO
9.10.3 REVENUE ANALYSIS
9.10.4 STRATEGIC INPUTS
9.10.5 SCOT ANALYSIS
9.11 SENSEONICS
9.11.1 BUSINESS PROFILE
9.11.2 PRODUCT PORTFOLIO
9.11.3 REVENUE ANALYSIS
9.11.4 STRATEGIC INPUTS
9.11.5 SCOT ANALYSIS
9.12 GLYSENS INCORPORATED
9.12.1 BUSINESS PROFILE
9.12.2 PRODUCT PORTFOLIO
9.12.3 STRATEGIC INPUTS
9.12.4 SCOT ANALYSIS

LIST OF TABLES

1. GLOBAL CGMS MARKET BY GEOGRAPHY, 2017-2025(IN US$ MILLION)
2. GLOBAL CGMS MARKET, BY DEVICE TYPE, 2017-2025(IN US$ MILLION)
3. GLOBAL SENSORS MARKET, 2017-2025(IN US$ MILLION)
4. GLOBAL TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
5. GLOBAL INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
6. GLOBAL CGMS MARKET, BY APPLICATION (2015 – 2025)
7. GLOBAL CGMS MARKET REVENUE, BY REGION, 2017-2025(IN US$ MILLION)

LIST OF FIGURES

1. GLOBAL CGMS MARKET SHARE, BY PRODUCT TYPE (2015)
2. GLOBAL SENSORS MARKET, 2017-2025(IN US$ MILLION)
3. GLOBAL TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
4. GLOBAL INSULIN PUMPMARKET, 2017-2025(IN US$ MILLION)
5. GLOBAL CGMS SHARE, BY APPLICATION (2015)
6. GLOBAL DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
7. GLOBAL HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
8. GLOBAL HOME SETTING MARKET, 2017-2025(IN US$ MILLION)
9. TOP THREE GEOGRAPHIES 2015
10. GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY (2016)
11. NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY (2016)
12. US CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
13. CANADA CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
14. EUROPE CGM MARKET SHARE, BY COUNTRY (2016)
15. GERMANY CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
16. UK CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
17. FRANCE CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
18. REST OF EUROPE (ROE)CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
19. ASIA PACIFIC CGM MARKET SHARE, BY COUNTRY (2015)
20. CHINA CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
21. INDIA CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
22. AUSTRALIA CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
23. ROAP CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
24. LATIN AMERICA CGM MARKET REVENUE, 2017-2025(IN USD MILLION)
25. ROW CGM MARKET REVENUE, 2017-2025(IN USD MILLION)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 持続血糖測定器(CGM)の世界市場(GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET FORECAST 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆